Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

35 results
Display

Recent Advances in Anti-Obesity Drugs

Son JW

Obesity is a chronic, complex, and heterogeneous disease that is affected by genetic, developmental, biological, and environmental factors; thus, it is necessary to approach obesity with an integrated and comprehensive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Updates of Pharmacotherapy for Smoking Cessation

Hwang JS, Lee CM

The use of tobacco, cigarette smoking in particular, is a leading causal factor of countless deaths and disabilities worldwide. Its widespread prevalence is a major global concern and is evidenced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Literature Review on the Efficacy and Related Neural Effects of Pharmacological and Psychosocial Treatments in Individuals With Internet Gaming Disorder

Seo EH, Yang HJ, Kim SG, Park SC, Lee SK, Yoon HJ

Objective Internet gaming disorder (IGD) has attracted considerable attention as a serious mental and public health issue worldwide. Currently, there are no established treatment guidelines for IGD. Herein, we review...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review

Tak YJ, Lee SY

As a chronic and relapsing disease, obesity negatiⓇvely impacts the health of men to a greater extent than that of women, with a higher risk of cardiovascular disease. Since lifestyle...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs

Son JW, Kim S

Obesity is among the leading causes of morbidity and mortality worldwide and its prevalence continues to increase globally. Because obesity is a chronic, complex, and heterogeneous disease influenced by genetic,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bupropion overdose as a clinically significant confounder of the neurological examination

Reyes R, Figueroa S

Background: Bupropion is a selective dopamine and norepinephrine reuptake inhibitor utilized in the treatment of multiple neuropsychiatric conditions. It has been implicated as a brain death mimic due to its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bupropion/Naltrexone (CONTRAVE ®)-induced Acute Generalized Exanthematous Pustulosis

Kim YS, Lee JH, Choi JE, Han TY

  • KMID: 2505574
  • Korean J Dermatol.
  • 2020 Aug;58(7):502-504.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Long-Term Pharmacotherapies for the Management of Obesity

Kim BY, Kang SM, Kang JH, Kim KK, Kim B, Kim SJ, Kim YH, Kim JH, Kim JH, Nam GE, Park JY, Son JW, Shin HJ, Oh TJ, Lee H, Jeon EJ, Chung S, Hong YH, Kim CH, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)

Obesity is a serious and growing worldwide health challenge associated with type 2 diabetes mellitus, cardiovascular disease, osteoarthritis, some cancers, sleep apnea, asthma, and nonalcoholic fatty liver. The Korean Society...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Current Management of Enduring Obesity in Diabetes

Kim CH

Obesity increases the risk of diabetes, hypertension, and cardiovascular diseases, ultimately contributing to mortality. The Korean Society for the Study of Obesity (KSSO) was established to improve the management of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness and Safety of Bupropion in Children and Adolescents with Depressive Disorders: A Retrospective Chart Review

Kweon K, Kim HW

OBJECTIVE: This study aimed to investigate the effectiveness and safety of bupropion extended-release for the treatment of depressive disorder in children and adolescents. METHODS: This was a 12-week, retrospective chart review...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Augmentation of Aripiprazole versus Bupropion on Specific Symptoms of Depression in Older Adult Patients : A Post-Hoc, Multi-Center, Open-Label, Randomized Study

Jo S, Cheon E, Lee K, Koo B, Park Y, Lee J, Lee S, Sung H

OBJECTIVES: The purpose of this study was to compare aripiprazole versus bupropion augmentation therapy in older adult patients with major depressive disorder unresponsive to selective serotonin reuptake inhibitors(SSRIs). METHODS: This is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity

Richards J, Gould JB, Laurin EG, Albertson

Cardiovascular and central nervous system (CNS) toxicity, including tachydysrhythmia, agitation, and seizures, may arise from cocaine or bupropion use. We report acute toxicity from the concomitant use of cocaine and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea

Kim KK

The Korean Ministry of Food and Drug Safety has approved three anti-obesity drugs for long-term management in the past decade. In addition, since 2019, bariatric surgery has been financially supported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Bupropion versus Aripiprazole Adjunctive Therapy for the Treatment of Female Depression : Post-Hoc Analyses from a Randomized Prospective Open-Label Multi-Center Study

Keum MS, Cheon EJ, Lee KH, Koo BH, Lee YJ, Park YW, Lee JH, Lee SJ, Sung HM

OBJECTIVES: The purpose of this study was to examine effects of adjunctive aripiprazole versus bupropion, on depressive symptoms of female depression. METHODS: Sixty six female patients with major depressive disorders were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012

Kwak MJ, Kim J, Bhise V, Chung TH, Petitto GS

OBJECTIVES: Smoking cessation decreases morbidity and mortality due to chronic obstructive pulmonary disease (COPD). Pharmacotherapy for smoking cessation is highly effective. However, the optimal prescription rate of smoking cessation medications...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder

Nam B, Bae S, Kim SM, Hong JS, Han DH

OBJECTIVE: Several studies have suggested the efficacy of bupropion and escitalopram on reducing the excessive internet game play. We hypothesized that both bupropion and escitalopram would be effective on reducing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tardive Dyskinesia Associated with Bupropion

Tuman TC, Çakır U, Yıldırım O, Camkurt MA

Present report describes a 46 year old male patient with a diagnosis of major depression who developed tardive dyskinesia during bupropion therapy. Our patient had no history of neuroleptic use...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment

Hou YC, Lai CH

The impacts from the bupropion on the brain structures have seldom been mentioned in the literature. The bupropion is a kind of antidepressant with dual action in the norepinephrine and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety of Anti-Obesity Drugs Approved for Long-Term Use

Kim KK

Because of the widespread use of ant-obesity medications, bariatricians need to be aware not only of common adverse events but also uncommon serious events in the pharmacotherapy of obesity. Safety...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bupropion for Interferon-Alpha-Induced Depression in Patients with Hepatitis C Viral Infection: An Open-Label Study

Chen WC, Lai HC, Su WP, Palani M, Su KP

Interferon (IFN)-alpha therapy for chronic hepatitis C virus (HCV) infection is frequently associated with major depressive episodes. Bupropion, a commonly used antidepressant agent, has recently found to have strong anti-inflammatory...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr